#29: TheMachine: PYTO Stock News : A Senior Cancer Researcher Joins PhytoMedical on Heels of Company’s Successful Preclinical Study on Human Brain Cancer
PhytoMedical’s compound for difficult-to-treat human brain cancer
... |
April 13, 2009
08:06:13 PM |
#28: Stock News Bot: PYTO PhytoMedical’s Patented Anti-Cancer Compound Eradicates Tumor in Successful In-Vivo Tests against Human Brain Cancer PhytoMedical’s compound for difficult-to-treat human brain cancer reveals case of “tumor cured”; demonstrates prolonged survival rat
PhytoMedical’s Patented Anti-Cancer Compound Eradicates Tumor in Successful... |
February 3, 2009
09:08:42 AM |
#27: TheMachine: PhytoMedical Advances Research of Patented Anti-Cancer Compound with Important Toxicity Tests
PhytoMedical’s anti-cancer compounds
shown to successfully... |
March 18, 2008
07:07:20 AM |
#26: TheMachine: PhytoMedical's Latest Anti-Cancer Compounds Kill Human Colon Cancer Cells
New tests show PhytoMedical’s ‘next-generation’
compounds kill... |
March 18, 2008
07:06:58 AM |
#25: TheMachine: PhytoMedical Bolsters Cancer Research Following Favorable Results
Patented anticancer compounds demonstrate special ability to kill
... |
February 5, 2008
08:45:18 AM |
#24: TheMachine: PhytoMedical's Patented Anti-Cancer Compounds Kill Lung Cancer Cells, a Significant New Finding
Novel class of antitumor compounds are designed to bind to DNA and kill... |
January 24, 2008
10:17:08 PM |
#23: TheMachine: Beacon Equity Research announces the availability of TraderNotes on stocks that are making news today
Beacon Research Issues TraderNotes on XSNX, NOEC, PYTO, CELG, AERO
DALLAS, Jan.... |
January 15, 2008
02:07:10 PM |
#22: Stock News Bot: PhytoMedical's Anti-Cancer Compound Effective at Killing Brain Cancer Cells
Novel Class of Patented Anti-Cancer Compounds Demonstrates
Significant... |
January 3, 2008
08:01:13 PM |
#21: Stock News Bot: PhytoMedical Expands Scope of Patented Technology That Kills Cancer Cells
Novel Class of Anti-Cancer Agents Block Cancer Cell DNA Replication
... |
December 20, 2007
12:54:06 PM |
#20: Stock News Bot: PYTO News PhytoMedical Continues to Strengthen Research and Development Team with Key Appointment
PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO)... |
March 26, 2007
07:16:00 AM |
#19: Stock News Bot: PYTO News PhytoMedical Furthers Development of New Class of Compounds for Type-2 Diabetes
PRINCETON, N.J.--(BUSINESS WIRE)--As part of the Company’s ongoing efforts... |
March 7, 2007
06:15:00 AM |
#18: Stock News Bot: PYTO News Expert in Pharmaceutical Sciences and New Drug Applications to FDA Joins PhytoMedical
PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB:PYTO)... |
February 21, 2007
06:15:00 AM |
#17: Stock News Bot: PYTO News PhytoMedical Finalizing Transition of Diabetes Compound Development
PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO)... |
January 16, 2007
06:15:00 AM |
#16: Stock News Bot: PYTO News PhytoMedical to Fast Track Development of New Class of Drug for Type-2 Diabetes
PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO)... |
December 4, 2006
06:15:00 AM |
#15: Stock News Bot: PYTO News Global Pharmacology Expert Joins PhytoMedical
PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB:PYTO)... |
October 11, 2006
06:15:00 AM |
